ELIZABETH MANSUR: Open Payments
NPI 1992395123 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 16 payments from 8 companies in 2025. Trend: 2023 $13 · 2024 $242 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $154 |
| Alkermes, Inc. | 4 | $69 |
| E.R. Squibb & Sons, L.L.C. | 1 | $38 |
| Lundbeck LLC | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $28 |
| ABBVIE INC. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: INVEGA SUSTENNA, ARISTADA, SPRAVATO, COBENFY, REXULTI, CAPLYTA, VRAYLAR, UZEDY.
Industry payments across KS — which companies pay providers there.
